These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34769184)

  • 1. The Initial Cardiac Tissue Response to Cryopreserved Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells in Rats with Chronic Ischemic Cardiomyopathy.
    Follin B; Hoeeg C; Højgaard LD; Juhl M; Lund KB; Døssing KBV; Bentsen S; Hunter I; Nielsen CH; Ripa RS; Kastrup J; Ekblond A; Kjaer A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study.
    Kastrup J; Haack-Sørensen M; Juhl M; Harary Søndergaard R; Follin B; Drozd Lund L; Mønsted Johansen E; Ali Qayyum A; Bruun Mathiasen A; Jørgensen E; Helqvist S; Jørgen Elberg J; Bruunsgaard H; Ekblond A
    Stem Cells Transl Med; 2017 Nov; 6(11):1963-1971. PubMed ID: 28880460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy.
    Chin SP; Poey AC; Wong CY; Chang SK; Teh W; Mohr TJ; Cheong SK
    Cytotherapy; 2010; 12(1):31-7. PubMed ID: 19878080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure.
    Qayyum AA; Mouridsen M; Nilsson B; Gustafsson I; Schou M; Nielsen OW; Hove JD; Mathiasen AB; Jørgensen E; Helqvist S; Joshi FR; Johansen EM; Follin B; Juhl M; Højgaard LD; Haack-Sørensen M; Ekblond A; Kastrup J
    ESC Heart Fail; 2023 Apr; 10(2):1170-1183. PubMed ID: 36638837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose-derived stromal cell therapy improves cardiac function after coronary occlusion in rats.
    Bagno LL; Werneck-de-Castro JP; Oliveira PF; Cunha-Abreu MS; Rocha NN; Kasai-Brunswick TH; Lago VM; Goldenberg RC; Campos-de-Carvalho AC
    Cell Transplant; 2012; 21(9):1985-96. PubMed ID: 22472303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats.
    Ishikane S; Hosoda H; Yamahara K; Akitake Y; Kyoungsook J; Mishima K; Iwasaki K; Fujiwara M; Miyazato M; Kangawa K; Ikeda T
    Transplantation; 2013 Oct; 96(8):697-706. PubMed ID: 23912174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of mesenchymal stem cells enhances the therapeutic effects of skeletal myoblast cell-sheet transplantation in a rat ischemic cardiomyopathy model.
    Shudo Y; Miyagawa S; Ohkura H; Fukushima S; Saito A; Shiozaki M; Kawaguchi N; Matsuura N; Shimizu T; Okano T; Matsuyama A; Sawa Y
    Tissue Eng Part A; 2014 Feb; 20(3-4):728-39. PubMed ID: 24164292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramyocardial transplantation of human adipose-derived stromal cell and endothelial progenitor cell mixture was not superior to individual cell type transplantation in improving left ventricular function in rats with myocardial infarction.
    Hong SJ; Kihlken J; Choi SC; March KL; Lim DS
    Int J Cardiol; 2013 Apr; 164(2):205-11. PubMed ID: 21794931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study.
    Tano N; Narita T; Kaneko M; Ikebe C; Coppen SR; Campbell NG; Shiraishi M; Shintani Y; Suzuki K
    Mol Ther; 2014 Oct; 22(10):1864-71. PubMed ID: 24930600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic Mesenchymal Stromal Cells Transplanted Onto the Heart Surface Achieve Therapeutic Myocardial Repair Despite Immunologic Responses in Rats.
    Tano N; Kaneko M; Ichihara Y; Ikebe C; Coppen SR; Shiraishi M; Shintani Y; Yashiro K; Warrens A; Suzuki K
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26896478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.
    Luger D; Lipinski MJ; Westman PC; Glover DK; Dimastromatteo J; Frias JC; Albelda MT; Sikora S; Kharazi A; Vertelov G; Waksman R; Epstein SE
    Circ Res; 2017 May; 120(10):1598-1613. PubMed ID: 28232595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cord lining-mesenchymal stem cells graft supplemented with an omental flap induces myocardial revascularization and ameliorates cardiac dysfunction in a rat model of chronic ischemic heart failure.
    Lilyanna S; Martinez EC; Vu TD; Ling LH; Gan SU; Tan AL; Phan TT; Kofidis T
    Tissue Eng Part A; 2013 Jun; 19(11-12):1303-15. PubMed ID: 23448654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction.
    Cai A; Zheng D; Dong Y; Qiu R; Huang Y; Song Y; Jiang Z; Rao S; Liao X; Kuang J; Dai G; Mai W
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):857-66. PubMed ID: 21983658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart.
    Klopsch C; Skorska A; Ludwig M; Lemcke H; Maass G; Gaebel R; Beyer M; Lux C; Toelk A; Müller K; Maschmeier C; Rohde S; Mela P; Müller-Hilke B; Jockenhoevel S; Vollmar B; Jaster R; David R; Steinhoff G
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29752300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of bone marrow- and adipose tissue-derived mesenchymal stem cell transplantation on myocardial remodelling in the rat model of ischaemic heart failure.
    Karpov AA; Uspenskaya YK; Minasian SM; Puzanov MV; Dmitrieva RI; Bilibina AA; Anisimov SV; Galagudza MM
    Int J Exp Pathol; 2013 Jun; 94(3):169-77. PubMed ID: 23560418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transplantation of adipose-derived mesenchymal stem cell improves cardiac function in rats with acute myocardial infarction].
    Wang Z; Yang Y; Wang Q; Qu S; Ding Y; Luan Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jan; 35(1):31-38. PubMed ID: 30914113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.
    Sun SJ; Lai WH; Jiang Y; Zhen Z; Wei R; Lian Q; Liao SY; Tse HF
    Theranostics; 2021; 11(4):1641-1654. PubMed ID: 33408772
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemokine stromal cell-derived factor 1/CXCL12 increases homing of mesenchymal stem cells to injured myocardium and neovascularization following myocardial infarction.
    Zhuang Y; Chen X; Xu M; Zhang LY; Xiang F
    Chin Med J (Engl); 2009 Jan; 122(2):183-7. PubMed ID: 19187644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of human adipose stem cells in a rat myocardial infarction model.
    Hwangbo S; Kim J; Her S; Cho H; Lee J
    Yonsei Med J; 2010 Jan; 51(1):69-76. PubMed ID: 20046516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.